Date | Time | Source | Announcement |
---|---|---|---|
19 Mar 2008 | 07:00 AM | Regulatory Update | |
01 Feb 2008 | 07:01 AM | Research Update | |
07 Jan 2008 | 01:42 PM | Director/PDMR Shareholding | |
03 Jan 2008 | 01:28 PM | Regulatory Update | |
11 Dec 2007 | 07:00 AM | To Present at Conference | |
03 Dec 2007 | 07:01 AM | Interim Results | |
28 Nov 2007 | 11:25 AM | To Present at US Conference | |
28 Nov 2007 | 11:13 AM | Notice of Results | |
21 Nov 2007 | 11:30 AM | Research Update | |
18 Oct 2007 | 07:01 AM | Research Update | |
06 Sep 2007 | 11:12 AM | AGM Result | |
06 Sep 2007 | 07:00 AM | Research Update | |
20 Aug 2007 | 07:02 AM | Re: AIM Rule 26 | |
10 Aug 2007 | 12:53 PM | Holding(s) in Company | |
08 Aug 2007 | 05:27 PM | Director/PDMR Shareholding | |
08 Aug 2007 | 04:59 PM | Director/PDMR Shareholding | |
08 Aug 2007 | 04:58 PM | Director/PDMR Shareholding | |
08 Aug 2007 | 04:56 PM | Director/PDMR Shareholding | |
08 Aug 2007 | 04:44 PM | Director/PDMR Shareholding | |
02 Aug 2007 | 12:12 PM | Increase in Share Capital | |
27 Jul 2007 | 07:01 AM | Acquisition | |
20 Jul 2007 | 11:17 AM | Notice of AGM | |
27 Jun 2007 | 07:01 AM | Final Results | |
22 Jun 2007 | 07:00 AM | Research Update | |
15 Jun 2007 | 12:10 PM | Notice of Results | |
15 Jun 2007 | 07:00 AM | ISSCR Conference | |
31 May 2007 | 07:00 AM | Re: New Data | |
18 May 2007 | 07:00 AM | Re: Collaboration | |
10 May 2007 | 01:04 PM | Rodman & Renshaw Conference | |
01 May 2007 | 10:50 AM | Re: Stem Cell Conference | |
25 Apr 2007 | 04:41 PM | Advanced Therapies Regulation | |
17 Apr 2007 | 07:00 AM | Patent Grant | |
12 Apr 2007 | 12:09 PM | Holding(s) in Company | |
12 Apr 2007 | 07:00 AM | Holding(s) in Company | |
23 Mar 2007 | 10:57 AM | Holding(s) in Company | |
06 Mar 2007 | 02:27 PM | Re: Stem Cell conference | |
26 Feb 2007 | 08:00 AM | Revenue-Sharing Agreement | |
16 Feb 2007 | 07:00 AM | Allotment of Shares | |
13 Feb 2007 | 07:00 AM | Holding(s) in Company | |
12 Feb 2007 | 01:00 PM | ReNeuron to Present | |
06 Feb 2007 | 11:24 AM | Holding(s) in Company | |
06 Feb 2007 | 07:00 AM | Fundraising | |
31 Jan 2007 | 09:38 AM | Shares notification | |
31 Jan 2007 | 09:37 AM | Shares notification | |
24 Jan 2007 | 07:00 AM | Secures Funding | |
18 Jan 2007 | 07:00 AM | Holding(s) in Company | |
12 Jan 2007 | 10:02 AM | Regulatory Update | |
09 Jan 2007 | 12:38 PM | Holding(s) in Company | |
09 Jan 2007 | 07:00 AM | Regulatory Update | |
27 Dec 2006 | 07:01 AM | Total Voting Rights |
ReNeuron Group plc is a United Kingdom-based clinical-stage stem cell company. The Company is engaged in the development of stem cell therapies targeting areas of unmet or poorly met medical need. It has developed a stem cell-derived, exosome-based, drug delivery platform with customizable cellular targeting capabilities for the delivery of complex drug modalities. Through the generation of several exosome producer cell lines, its CustomEX platform can be optimized for specific tissue targets and payloads, leading to improvements in therapeutic outcome and a reduction in off-target effects. It offers a delivery mechanism for a variety of payloads such as small interfering Ribonucleic Acid (siRNA), messenger RNA (mRNA), proteins, small molecules and genes. Through its conditionally immortalized induced pluripotent stem cell (iPSC) platform, it has the ability to make allogeneic tissue cells of choice and has the potential to produce exosomes with tissue specific targeting ability.
It listed on AIM in 2006 under the ticker RENE.